Home
Karuna Therapeutics

Karuna Therapeutics Market Share Analysis for June 2026

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Health > Biotechnology and Pharmaceuticals

Domainkarunatx.com

Year Founded2009

Employees51 - 200

Annual Revenue$25M - $50M

Karuna Therapeutics

Karuna Therapeutics (including company regionals)

karunatx.com

See more website traffic and engagement information

Karuna Therapeutics Revenue up to June 2026 is 25M - 50M

revenue generated by Karuna Therapeutics top domains

Karuna Therapeutics top domains revenue over 3 years

Revenue for Karuna Therapeutics top domains

karunatx.com25M - 50M

See more with Sales Intelligence

Total visits to Karuna Therapeutics's top domains

Understand Karuna Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Karuna Therapeutics's top domains

Analyze Karuna Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Karuna Therapeutics's top domains

See how Karuna Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Karuna Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Karuna Therapeutics

These are the website technologies, by industry, used by Karuna Therapeutics top domains

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

9

See all

News & Signals from Karuna Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAngel Angelov leaves Karunatx as chief medical officer.Vistagen names former Karuna and Neurocrine executive Angel Angelov chief medical officer.

NewsSteven Paul leaves Karunatx as chair.Seaport Therapeutics is captained by CEO Daphne Zohar, a co-founder of Karuna, with Karuna's former CEO Steven Paul, M.D., serving as the chair of Seaport's board of directors.

NewsKarunatx is developing KarXT.Karuna Therapeutics is developing a novel product, KarXT, to treat psychoses related to Alzheimer's and schizophrenia.